Tag: bad ad program

07/26/2021

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery

CHC_DTCadvertisement2

03/15/2021

Two Recent OPDP Letters Prompted by “Bad Ad Program” Complaints

FDA-News (1)

10/12/2020

Bad Ad Complaints Yield Two OPDP Warning Letters, One on COVID Email Claims

CHC_offLabel

12/22/2017

FDA To Study Consumer, HCP Ability to Spot Deceptive Drug Ads

CHC_FDA-Regulatory Images1

01/04/2017

FDA Will Study Consumer and HCP Ability to Identify Deceptive Drug Promotion

01/06/2012

OPDP to Industry: Voluntary Compliance Efforts in New Year Can Prevent Same Old Violations

05/12/2010

FDA Launches Bad Ad Program